-
Suspect remains silent in Swiss bar fire probe
-
Italy great Parisse appointed Azzurri forwards coach
-
Iran truce spurs hopes for world economy, but recovery will be rocky
-
BAFTA racial slur was breach of BBC editorial standards: internal probe
-
Red or black: Thai men tempt fate at military draft draw
-
CAF president visits Dakar following AFCON trophy reversal
-
Medvedev thrashed 6-0, 6-0 by Berrettini in Monte Carlo
-
Australia's O'Callaghan sets sights on Titmus's 200m freestyle world record
-
Oil prices plunge, stocks surge on US-Iran ceasefire
-
Researchers unmask trade in nude images on Telegram
-
Warner aware of 'seriousness' of drink-driving charges: Cricket NSW
-
Indian hit movie 'Dhurandhar' breaks Bollywood records
-
Australia PM welcomes Iran ceasefire, says Trump threats not 'appropriate'
-
Nigeria sweats in heatwave as Iran war drives up costs to stay cool
-
'Pinprick of light': Artemis crew witnesses meteorite impacts on Moon
-
German factory orders rise in February but energy shock looms
-
China says investigating 'malicious' cyberbullying of teen diving star
-
North Korea fires two rounds of ballistic missiles: Seoul military
-
Taiwan opposition leader says China visit to sow 'seeds of peace'
-
Jet fuel supplies to take 'months' to recover from war disruption: IATA
-
How did Pakistan broker a temporary truce between Iran and the US?
-
North Korea fires multiple ballistic missiles in two rounds: Seoul military
-
Rockets comeback sinks Phoenix on Durant return
-
'Ketamine Queen' to be sentenced over Matthew Perry death
-
Vietnam's To Lam bets big on building blitz
-
Sooryavanshi, 15, hailed as 'amazing, fearless' after acing Bumrah test
-
Pakistan to host US-Iran ceasefire talks Friday
-
Middle East war: ceasefire reactions
-
North Korea fires multiple ballistic missiles towards East Sea
-
Both sides claim victory after US, Iran agree to 11th-hour truce
-
Unbeaten legend Winx's $7 million foal retires without racing
-
Trump to AFP: Iran deal 'total and complete victory' for US
-
Solar push helps Pakistan temper Gulf energy shock
-
Crude prices plunge, stocks surge as US and Iran agree ceasefire
-
Wave of nostalgia as 2000s TV makes a comeback
-
Iraqi armed group releases US journalist
-
Forest's Igor Jesus eyes Europa League 'dream', Villa brace for Bologna in quarters
-
In-demand prop De Lutiis rebuffs Ireland to commit to Australia
-
US, Iran agree to 11th-hour truce after Trump apocalyptic threats
-
Konica Minolta Announces First Class of 2026 Pro-Tech Service Award Recipients
-
Devon's Dissertation Symposium Launches Student-Focused Academic Support Services for Graduate Researchers
-
EQS Group Shortlisted in Two Categories at ICA Compliance Awards Europe 2026
-
Medical Care Technologies (OTC Pink:MDCE) Expands AI Monetization Strategy and Advances Pipeline of AI Applications
-
Oar & Iron Raw Bar & Grill Arrives in Babcock Ranch
-
Pace Life Sciences To Deliver Two Speaker Sessions at Society of Quality Assurance (SQA) Annual Meeting 2026
-
Chilean Cobalt Corp. Continues Accelerated Drilling, Defines Initial Development Target, and Advances Engineering at NeoRe Rare Earth Project
-
SoloTruth Launches Asset Relationship Management (ARM) Platform for Real-Time Fixed Asset Verification
-
Clean Vision Announces Retirement of Convertible Note, Clean-Seas West Virginia to receive 2TPD Pyrolysis Reactor
-
Time Doctor Wins Gold at 2026 Reworked IMPACT Awards in Work Management & Project Management Category
-
5E Advanced Materials to Participate in Water Tower Research Insights Conference on April 14, 2026
Mentavi Health Reflects on a Defining 2025 and Outlines Responsible Growth Plans for 2026
Peer-reviewed validation study, expanding institutional adoption, and human-centered innovation reinforce Mentavi's leadership in mental health care
GRAND RAPIDS, MI / ACCESS Newswire / January 28, 2026 / Mentavi Health, a leader in evidence-based digital mental health care, today released its 2025 Year in Review, highlighting a year marked by peer-reviewed clinical validation, broad institutional adoption, and continued leadership in ethical, human-centered mental health care. The company also outlined its priorities for 2026, centered on trusted partnerships, responsible innovation, and expanded access to high-quality mental health services for adults.
"2025 was a defining year for Mentavi," said Keith Brophy, CEO of Mentavi Health. "We demonstrated that technology-enabled mental health care can meet rigorous clinical standards while remaining accessible and grounded in human oversight. As we move into 2026, our focus is on deepening trust with partners, maintaining strong clinical and ethical foundations, and continuing to put people, not technology, at the center of care."
Peer-Reviewed Clinical Validation
In 2025, Mentavi achieved a significant clinical milestone with the peer-reviewed validation of its adult ADHD diagnostic evaluation, demonstrating that its clinician-reviewed, asynchronous assessment showed substantial agreement with a clinical interview used in adult ADHD evaluation in real-world clinical settings.
Key Mentavi Clinical Study milestones included:
First public presentation of real-world validation data at the 2025 World ADHD Congress in Prague, Czech Republic
Peer-reviewed publication in the Journal of Clinical Psychiatry
First U.S. presentation of findings at the Neuroscience Education Institute Annual Meeting in Colorado Springs
These findings support Mentavi's role as a trusted diagnostic resource for health care professionals who diagnose and treat mental health conditions, as well as for higher-education institutions, workforce organizations, and regulators.
Expanding Adoption Across Key Sectors
During 2025, Mentavi's validated diagnostic approach saw growing adoption across education, clinical care, and workforce-focused organizations.
Higher education: Mentavi has historically served dozens of colleges and universities, with tens of thousands of student evaluations completed over time, including a continued flagship partnership at Santa Barbara City College.
Clinical practices: Mental health practices, including Quintessence Psychiatry, adopted Mentavi's platform as a diagnostic support resource, with referral-driven use representing a growing share of overall volume.
Workforce and coaching: Partnerships expanded with organizations supporting executive performance, educational therapy, and adult coaching.
Collectively, these developments reflect a shift toward integrated, partner-based care pathways rather than standalone direct-to-consumer use.
Human-Centered Care and Ethical AI
Mentavi continued to emphasize online human-centric care at scale in 2025:
All evaluations are reviewed and finalized by licensed clinicians, with no standalone AI diagnosis or treatment.
Evaluations remain affordable and timely, with transparent, flat-rate pricing, and results typically delivered within five days.
AI tools are used only as an assistive digital concierge to enhance clarity, engagement, and transparency-never to replace clinician judgment.
The company also strengthened oversight through a multidisciplinary AI Ethics and Governance Committee, ensuring responsible use of technology across clinical, technical, and compliance domains.
Privacy, Compliance, and Consumer Trust
Throughout 2025, Mentavi focused on strengthening consumer trust by:
Maintaining alignment with evolving federal and state regulations
Continuing to evolve internal patient support, outreach, QA and compliance practices in line with industry best practices
Achieving Better Business Bureau accreditation, reflecting sustained improvements in patient experience
Patient Reach and Emerging Insights
Since its founding in 2018, Mentavi has served more than 220,000 individuals to date across a broadening range of mental health needs. Emerging trends observed during 2025 included increasing presentations of anxiety and depression without ADHD, growing signals related to loneliness and social isolation, and a platform population that disproportionately serves adult women-helping address a long-recognized diagnostic gap in ADHD. Mentavi will continue to monitor these trends and use them to inform future clinical and research priorities.
Looking Ahead Through 2026
Building on 2025 momentum, Mentavi's 2026 outlook includes:
An APSARD (American Professional Society for ADHD and Related Disorders) poster presentation highlighting Mentavi's clinical research (January 2026)
A poster presentation at the Nevada Psychiatric Association Psychopharmacology Annual Conference (February 11-14, 2026)
A poster presentation at the American Psychiatric Association Annual Meeting (May 16, 2026)
Expanded executive and clinical thought-leadership initiatives
Continued emphasis on ethical AI, regulatory engagement, and partner-led growth
"Our goal for 2026 is steady, responsible progress," Brophy added. "We are committed to advancing mental health care in ways that are clinically sound, ethically grounded, and worthy of trust."
About Mentavi Health
Founded in 2018 as ADHD Online and recognized as one of Michigan's "50 Companies to Watch," Mentavi Health provides evidence-based, compliant online mental health care nationwide. Its clinically validated Diagnostic Evaluation for diagnosing adult ADHD serves as the foundation for broader mental health assessment, including anxiety, depression, and related conditions. Mentavi delivers affordable, high-quality care through licensed clinicians, offering diagnostic evaluations, therapy, medical treatment, and mental wellness coaching. Guided by clinical rigor, accessibility, compliance, and trust, Mentavi is redefining how people connect to quality mental health care. Mentavi serves adults aged 18 and older. Services are available by state; availability may vary. Learn more at mentavi.com.
Media contact:
Tim Cox, ZingPR for Mentavi Health
[email protected]
SOURCE: Mentavi Health
View the original press release on ACCESS Newswire
H.Gonzales--AT